# Using the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma Exacerbations

> **NCT05417906** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Changi General Hospital** · enrollment: 110 (estimated)

## Conditions studied

- Asthma Attack
- Asthma

## Interventions

- **OTHER:** Standard care
- **OTHER:** Eosinophil-directed care

## Key facts

- **NCT ID:** NCT05417906
- **Lead sponsor:** Changi General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-06-02
- **Primary completion:** 2025-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2024-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05417906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05417906, "Using the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma Exacerbations". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05417906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*